Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
20–any
Sex
MALE
Healthy volunteers
Not accepted
Inclusion Criteria:
* Patients with castration-resistant prostate cancer and serum testosterone ≤50 ng/dL progressive to current therapy who satisfy the inclusion and exclusion criteria
Clareo Health | A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer
